Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCP Infrastructure Investments Regulatory News (GCP)

Share Price Information for GCP Infrastructure Investments (GCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.20
Bid: 77.00
Ask: 77.10
Change: 0.00 (0.00%)
Spread: 0.10 (0.13%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 77.20
GCP Live PriceLast checked at -
GCP Infrastructure Investments is an Investment Trust

To provide shareholders with regular, sustainable, long-term dividend income and to preserve the capital value of its investments over the long term by generating exposure to infrastructure debt and/or similar assets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results - Placing, Open Offer & C Share Offer

13 Mar 2014 11:40

RNS Number : 2367C
GCP Infrastructure Investments Ltd
13 March 2014
 



NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS OR INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

 

This announcement is not a prospectus. This announcement does not constitute or form part of, and should not be construed as, any offer or invitation to sell, issue, purchase or subscribe for, or any solicitation of any offer to sell, issue, purchase or subscribe for, any shares in the Company or securities in any other entity nor shall it, or any part of it, or the fact of its distribution, form the basis of, or be relied on in connection with, any contract or investment decision in relation thereto. This announcement does not constitute a recommendation regarding any securities.

 

 

GCP Infrastructure Investments Limited (the "Company")

 

Result of Placing, Open Offer and Offer for Subscription of C Shares

 

13 March 2014

 

On 20 January 2014, the Company announced its intention to raise additional capital through a Placing, Open Offer and Offer for Subscription of C Shares of £0.01 each (the "C Shares") at an issue price of £1.00 per C Share (the "Issue") and the creation of a placing programme in relation to its Ordinary Shares of £0.01 each (the "Ordinary Shares") (the "Placing Programme"). 

 

The Company is pleased to announce today that the Issue has been significantly oversubscribed. Taking into account the lending opportunities available for investment in the near term, the Company will accept gross proceeds under the Issue of £80 million.

 

As the Issue was considerably oversubscribed, applications under the Issue will be scaled back in accordance with the terms and conditions set out in the Prospectus; however all applications made pursuant to Basic Entitlements under the Open Offer will be met in full.

 

A total of 80,000,000 C Shares will be issued (subject to Admission), of which 50,682,580 C Shares will be issued pursuant to the Open Offer and 29,317,420 C Shares will be issued pursuant to the Placing and the Offer for Subscription.

 

Application has been made for the C Shares to be admitted to the Official List and to trading on the London Stock Exchange's Main Market for listed securities ("Admission"). It is expected that Admission will become effective and dealings in the C Shares will commence on 18 March 2014.

 

Commenting on the fundraising, Ian Reeves CBE, Chairman, said:

"We are delighted with the support demonstrated by both existing shareholders and new investors for this equity raise. The strong demand for shares is a pleasing endorsement of our success in delivering the Company's investment objective to provide shareholders with regular, sustainable, long-term distributions and to preserve the capital value of its investment assets over the long term. The Board remains focused on this objective and as a result, the proceeds raised have been capped at £80 million in order to execute the specifically identified investment opportunities available to the Company in the near future."

Following Admission, the Company expects to have 355,058,164 Ordinary Shares and 80,000,000 C Shares in issue. The International Security Identification Number for the C Shares is JE00BJT12C24 and the TIDM is GCPI. The total number of voting rights of the Company will be 435,058,164 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company.

 

 

Contact details:

 

Gravis Capital Partners LLP

Stephen Ellis

Rollo Wright

 

 

+44 (0)20 7518 1495

+44 (0)20 7518 1493

Oriel Securities

Mark Bloomfield

Tunga Chigovanyika

Neil Winward

 

+44 (0)20 7710 7600

Cenkos Securities

Dion Di Miceli

Tom Scrivens

 

+44 (0)20 7397 1921

+44 (0)20 7397 1915

Buchanan

Charles Ryland

Sophie McNulty

 

 

+44 (0)20 7466 5000

Words and expressions that are defined in the prospectus published on 12 February 2014 by the Company shall have the same meanings where they are used in this announcement, except where the context requires otherwise.

 

This announcement is not for distribution, directly or indirectly, in or into the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia) (the "United States"), Australia, Canada, Japan or South Africa. This announcement does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase, any securities in the United States, Australia, Canada, Japan or South Africa. The securities of the Company have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act" or the US Investment Company Act of 1940, as amended) and may not be offered or sold directly or indirectly into the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The securities referred to herein have not been registered under the applicable securities laws of Australia, Canada, Japan or South Africa and, subject to certain exceptions, may not be offered or sold within Australia, Canada, Japan or South Africa or to any national, resident or citizen of Australia, Canada, Japan or South Africa.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQKNDQDBKDKND
Date   Source Headline
28th Apr 20236:11 pmRNSTotal Voting Rights
28th Apr 20235:00 pmRNSTransaction in Own Shares
28th Apr 20234:01 pmRNSChange of Registered Office
27th Apr 20237:00 amRNSNet Asset Value(s)
27th Apr 20237:00 amRNSDividend Declaration
19th Apr 20235:27 pmRNSTransaction in Own Shares
18th Apr 20235:49 pmRNSTransaction in Own Shares
5th Apr 20235:31 pmRNSTransaction in Own Shares
31st Mar 20235:18 pmRNSTotal Voting Rights
30th Mar 20237:00 amRNSDirector Declaration
29th Mar 20235:24 pmRNSTransaction in Own Shares
28th Mar 20234:53 pmRNSTransaction in Own Shares
27th Mar 20234:34 pmRNSTransaction in Own Shares
15th Mar 20235:15 pmRNSTransaction in Own Shares
14th Mar 20235:22 pmRNSTransaction in Own Shares
14th Mar 20237:00 amRNSShare Buyback Programme Initiated
23rd Feb 20237:00 amRNSDirector/PDMR Shareholding
20th Feb 202312:27 pmRNSHolding(s) in Company
15th Feb 202311:42 amRNSResult of AGM
13th Feb 20233:25 pmRNSHolding(s) in Company
7th Feb 20234:52 pmRNSUpdate research from QuotedData
2nd Feb 202310:34 amRNSInvestor Report at 31 December 2022
31st Jan 20233:52 pmRNSDirector/PDMR Shareholding
27th Jan 20237:00 amRNSNet Asset Value(s)
27th Jan 20237:00 amRNSDividend Declaration
12th Jan 20239:55 amRNSNotice of net asset value announcements
11th Jan 20239:15 amRNSDirector Declaration
9th Jan 20239:15 amRNSNotice of AGM
15th Dec 20227:00 amRNSAnnual report and financial statements
28th Oct 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSInvestor Report at 30 September 2022
26th Oct 20227:00 amRNSDividend Declaration
20th Oct 20227:00 amRNSNet Asset Value(s)
30th Sep 202211:13 amRNSResult of EGM
30th Sep 20227:00 amRNSTotal Voting Rights
13th Sep 20225:21 pmRNSNotice of EGM
6th Sep 20229:18 amRNSAdditional Listing and Total Voting Rights
25th Aug 20229:30 amRNSAdditional Listing
11th Aug 20227:00 amRNSScrip Share Reference Price
29th Jul 20227:00 amRNSInvestor Report at 30 June 2022
27th Jul 202212:37 pmRNSResearch from QuotedData
26th Jul 202210:59 amRNSDividend Declaration & Scrip Dividend Alternative
14th Jul 20227:00 amRNSNet Asset Value(s)
30th Jun 20227:00 amRNSTotal Voting Rights
21st Jun 20227:05 amRNSDirectorate Change
21st Jun 20227:00 amRNSHalf-yearly report and financial statements 2022
7th Jun 20229:43 amRNSAdditional Listing and Total Voting Rights
26th May 20229:17 amRNSAdditional Listing
20th May 20223:56 pmRNSHolding(s) in Company
12th May 20227:00 amRNSScrip Share Reference Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.